Hemostemix Inc. is a biotech company situated in Calgary, Canada, headed by Thomas A. Smeenk. The company manages the exploration, improvement, and assembling of inventive blood-derived stem cell therapies with marvelous recuperating and recovery properties bringing about less immunogenic variables.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.